baber/WOPTO huggingface dataset:
Patent MX-2019004677-A (MX)
Title: High strength and low stiffness agave tissue.
Inventor: THOMAS GERARD SHANNON
IPC: A47K10/16
Filed: 2016-10-27
Abstract: The disclosure provides tissue products comprising agave fibers and methods of producing the same. Preferably the agave fibers are high yield agave pulp fibers, which have demonstrated the ability to replace a substantial portion of the long fiber fraction of the furnish without negatively effecting important tissue product properties such as stiffness, CD Durability and bulk. Thus, the tissue product may comprise greater than about 10 weight percent agave fiber and more preferably greater than about 25 weight percent. Accordingly, in certain embodiments the present disclosure provides a three-layered through-air dried tissue product comprising high-yield agave fibers from the leaves of Agave tequilana, Eucalyptus Hardwood Kraft (EHWK) and Northern Softwood Kraft (NSWK), wherein the high-yield agave fibers comprise 10.0 percent by weight of the tissue product, the product having a CD durability greater than about 18 and sheet bulk greater than about 10 cc/g.
Patent MX-2019005232-A (MX)
Title: Piperidin-4-yl azetidine derivatives as jak1 inhibitors.
Inventor: JAMES D RODGERS
IPC: A61P35/00
Filed: 2012-09-06
Abstract: The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Patent MX-2019007367-A (MX)
Title: Peptide ligands for binding to mt1-mmp.
Inventor: DANIEL TEUFEL
IPC: C07K7/08
Filed: 2017-12-20
Abstract: A peptide ligand specific for MT1 -MMP comprising a polypeptide comprising two diaminopropionic acid (Dap) or N-alkyldiaminopropionic acid (N-AlkDap) residues, and a third residue selected from cysteine, Dap or N-AlkDap, separated by at least two loop sequences, and a molecular scaffold, the peptide being linked to the scaffold by covalent alkylamino linkages with the Dap or N-AlkDap residues of the polypeptide and by covalent thioether linkages with the cysteine when the third residue is cysteine, such that two polypeptide loops are formed on the molecular scaffold, wherein the peptide ligand comprises an amino acid sequence of formula (II): -A1-X1-U/O2-X3-X<su b>4-G5-A2-E6-D7</sub >-F8-Y9-X10-X11-A<su b>3- (SEQ ID NO: 1) (II) or a pharmaceutically acceptable salt thereof; wherein: A1, A2, and A3 are independently cysteine, L-2,3-diaminopropionic acid (Dap), N-beta-alkyl-L-2,3- diaminopropionic acid (N-AlkDap), or N-beta-haloalkyl-L-2,3-diaminopropionic acid (N- HAlkDap), provided that at least one of A1, A2, and A3 is Dap, N-AlkDap or N-HAlkDap; X represents any amino acid residue; U represents a polar, uncharged amino acid residue selected from N, C, Q, M, S and T; and O represents a non-polar aliphatic amino acid residue selected from G, A, I, L, P and V.
Patent MX-2019007731-A (MX)
Title: Receiving device.
Inventor: NAOHISA KITAZATO
IPC: H04N21/235
Filed: 2016-05-30
Abstract: The present technology relates to a receiving device that can select an optimal component. Provided is a receiving device that comprises a first receiving unit that receives video and audio components transmitted by broadcast waves, a second receiving unit that receives video and audio components transmitted via a network, and a control unit that controls the operation of each unit. The control unit selects optimal video and audio components from among a plurality of receivable video and audio component candidates.
Patent MX-2019013326-A (MX)
Title: Multicomponemt plasmonic photocatalysts consisting of a plasmonic antenna and a reactive catalytic surface: the antenna-reactor effect.
Inventor: ZHANG CHAO
IPC: B01J35/00
Filed: 2018-05-11
Abstract: A method of making a multicomponent photocatalyst, includes inducing precipitation from a pre-cursor solution comprising a pre-cursor of a plasmonic material and a pre-cursor of a reactive component to form co-precipitated particles; collecting the co-precipitated particles; and annealing the co-precipitated particles to form the multicomponent photocatalyst comprising a reactive component optically, thermally, or electronically coupled to a plasmonic material.
Patent MX-2020002769-A (MX)
Title: Dry powder compositions with magnesium stearate.
Inventor: YADIDI KAMBIZ
IPC: A61K31/616
Filed: 2017-09-26
Abstract: A stable dry powder composition for inhalation includes acetylsalicylic acid in particles having a mass median aerodynamic diameter (MMAD) in a range of about 1 Âµm to about 5 Âµm. The dry powder composition may contain a pharmaceutically acceptable excipient, such as a stearate, in an amount ranging from about 0.04% (w/w) to about 0.06% (w/w), or from about 0.4% (w/w) to about 0.6% (w/w), of the composition.
Patent MX-2020005947-A (MX)
Title: Dentifrice comprising zinc - amino acid complex.
Inventor: SZEWCZYK GREGORY
IPC: A61K8/27
Filed: 2017-12-13
Abstract: Disclosed herein are dentifrices comprising a zinc - amino acid complex together with a thickening system comprising a non-ionic thickening agent, which have a pH greater than 8.0. Methods of using the dentifrices are also provided.
Patent MX-2020008830-A (MX)
Title: Polyhalite enriched animal feed.
Inventor: MAGEN HILLEL
IPC: A23K10/00
Filed: 2019-05-05
Abstract: There is provided an animal feed composition comprising Polyhalite in a concentration between 0.5%-5% w/w.
Patent MX-2020012158-A (MX)
Title: Magl inhibitors.
Inventor: BUZARD DANIEL J
IPC: C07D213/55
Filed: 2019-05-14
Abstract: Provided herein are piperazine carbamates and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful as modulators of MAGL. Furthermore, the subject compounds and compositions are useful for the treatment of pain.
Patent MX-2020012559-A (MX)
Title: In situ polymerization process to obtain elastomeric nanocomposites with pristine cellulose nanocrystals/surface modified cellulose nanocrystals with acyclic terpenes by plasma.
Inventor: DÍAZ DE LEÓN GÓMEZ RAMÓN ENRIQUE
IPC: B82Y40/00
Filed: 2020-11-23
Abstract: The present invention relates to an innovative process for obtaining elastomeric nanocomposites, using the in situ polymerization method with monomers of renewable origin, ß-myrcene, trans-ß-farnesene, and pristine cellulose nanocrystals, obtaining 100% bio-based nanocomposites. Also, it allows achieving elastomeric nanocomposites with cellulose nanocrystals superficially modified with acyclic terpenes using plasma, improving the interaction of the nano-reinforcement with the matrix, as well as its dispersion to increase the properties and performance thereof.
Patent MX-2020013158-A (MX)
Title: MODIFIED Cas9 PROTEIN AND USE THEREOF.
Inventor: YAMAGATA TETSUYA
IPC: C07K19/00
Filed: 2019-06-07
Abstract: According to the present invention, a protein, which has the ability to bind to guide RNA and has a sequence which has, in the amino acid sequence represented by SEQ ID NO: 2, a continuous deletion region between position 481 and position 649, wherein amino acid residues adjacent to the deletion region are linked together by a linker including 3-10 amino acid residues, and wherein (i) the deletion region contains all or a portion of an L1 domain (positions 481-519), (ii) the deletion region contains an entire HNH domain (positions 520-628), and (iii) the deletion region optionally contains all or a portion of an L2 domain (positions 629-649), functions as a smaller-sized dSaCas9 protein while maintains DNA-binding affinity. The use of the smaller-sized dSaCas9 protein allows more genes to be incorporated into a vector.
Patent MX-2021001302-A (MX)
Title: Image encoding/decoding method and device, and recording medium storing bitstream.
Inventor: LEE JIN HO
IPC: H04N19/176
Filed: 2019-08-06
Abstract: An image decoding method is disclosed in the present specification. An image decoding method of the present invention comprises: a step of generating a candidate list including motion information derived from a temporal neighboring block and a spatial neighboring block adjacent to a current block; a step of deriving motion information of the current block by using the candidate list; a step of generating a prediction block of the current block by using the derived motion information; and a step of updating the derived motion information in a motion information list, wherein the step of generating the candidate list comprises generating the candidate list including at least one piece of motion information included in the motion information list updated in a block encoded before the current block.
Patent MX-2021001638-A (MX)
Title: Pr13.5 promoter for robust t-cell and antibody responses.
Inventor: STEIGERWALD ROBIN
IPC: A61P37/04
Filed: 2015-04-24
Abstract: The invention encompasses recombinant poxviruses, preferably modified Vaccinia Ankara (MVA) viruses, comprising a Pr13.5 promoter operably linked to a nucleotide sequence encoding an antigen and uses thereof. The invention is drawn to compositions and methods for the induction of strong CD8 T cell and antibody responses to a specific antigen(s) by administering one or more immunizations of the recombinant MVA to a mammal, preferably a human.
Patent MX-2021001897-A (MX)
Title: Steel material suitable for use in sour environment.
Inventor: ARAI YUJI
IPC: C22C38/00
Filed: 2019-09-26
Abstract: Provided is a steel material having a yield strength of 655-965 MPa (95-125 ksi grade) and excellent SSC resistance in a low-temperature sour environment. A steel material according to the present disclosure contains, in terms of % by mass, 0.20-0.35% C, 0.05-1.00% Si, 0.01-1.00% Mn, no more than 0.025% P, no more than 0.0100% S, 0.005-0.100% Al, 0.25-0.80% Cr, 0.20-2.00% Mo, 0.002-0.050% Ti, 0.0001-0.0050% B, 0.0020-0.0100% N, and no more than 0.0100% O, the remainder comprising Fe and impurities, and has a chemical composition satisfying formula (1). The number density of precipitates having an equivalent circle diameter of 400 nm or larger is 0.150/Âµm<sup>2</sup> or less in the steel material. The yield strength of the steel material is 655-965 MPa. The dislocation density Ï of the steel material is 7.0Ã10<sup>14</sup>m<sup>-2</sup> or less. (1): 5 Ã Cr-Mo-2 Ã (V + Ti) â¤ 3.00.
Patent MX-2021002824-A (MX)
Title: Filtration systems with multitiered data exchange capabilities.
Inventor: ANDERSON MATTHEW
IPC: F02M35/09
Filed: 2019-09-18
Abstract: Aspects herein include filtration systems with multitiered data exchange capabilities. In an embodiment, a filtration system with multitiered data exchange capabilities is included. The system can include a first data communication tier including a filter element, the filter element storing data, and a first sensor. The system can include a second data communication tier including a reader device in communication with the first sensor. The system can include a third data communication tier including an engine control unit (ECU) in communication with the reader device, wherein the ECU stores data. The second data communication tier receives data from the first data communication tier and the third data communication tier. The second data communication tier executes operations on the received data to create a processed data set. Further, the second data communication tier sends the processed data set to the third data communication tier. Other embodiments are also included herein.
Patent MX-2021003598-A (MX)
Title: Microorganisms for plant pathogen inhibition.
Inventor: KING MICHAEL R
IPC: A01H5/10
Filed: 2019-09-27
Abstract: The invention relates to treatment of a plant with one or more microorganisms for inhibiting a plant pathogen. More particularly, the invention relates to isolated Bacillus strains, and strains having all of the identifying characteristics of these strains, and combinations thereof, for a use comprising the above-mentioned use.
Patent MX-2021004600-A (MX)
Title: Crystal form of maleate of tyrosine kinase inhibitor and preparation method therefor.
Inventor: DU ZHENXING
IPC: A61P35/00
Filed: 2019-10-21
Abstract: Provided are a crystal form of a maleate of a tyrosine kinase inhibitor and a preparation method therefor. Specifically, provided are I crystal form, a II crystal form, a III crystal form, a IV crystal form and a V crystal form of the compound as shown in formula (I) and a preparation method therefor. The new crystal form has a good stability, thereby making same better to use in clinical treatments. ï¼Iï¼.
Patent MX-2021005560-A (MX)
Title: Therapy for treating cancer with an intratumoral and/or intravenous administration of a recombinant mva encoding 4-1bbl (cd137l) and/or cd40l.
Inventor: LAUTERBACH HENNING
IPC: A61K39/395
Filed: 2019-11-20
Abstract: The invention relates to a composition and related methods for reducing tumor volume and/or increasing the survival of a cancer patient. The composition comprises a recombinant MVA encoding a Tumor Associated Antigen ("TAA") as well as 4-1BBL and/or CD40L and can be administered to a subject in any suitable manner, including by intravenous and/or intratumoral administration.
Patent MX-2021007701-A (MX)
Title: Configurable modular hazardous location compliant circuit protection devices, systems and methods.
Inventor: MANAHAN JOSEPH MICHAEL
IPC: H01H9/04
Filed: 2019-12-26
Abstract: Modular circuit protection devices and configurable panelboard systems include arc-free operation, thermal management features providing safe operation in hazardous environments at lower cost and without requiring conventional explosion-proof enclosures and without entailing series connected separately provided packages such as circuit breaker devices and starter motor contactors and controls.
Patent MX-2021007743-A (MX)
Title: Culture substrate to increase the production of worms and cocoons.
Inventor: ZAVALA AGUIRRE JOSE LUIS
IPC: A01K67/033
Filed: 2021-06-24
Abstract: The present invention aims to provide a culture substrate to increase the production of worm cocoons. Said substrate consists of 10%-15% Vachellia pennatula litter as an organic food source for the organisms, 20%-30% kaolinite clay, and 55%-70% of fine industrial sand. Herein, clay and sand constitute the inert substrate for an adequate exchange of elements and gases between the organism and its environment. Also, it includes a humidity of approximately 35% with distilled water for keeping the organisms hydrated but without saturating the soil, allowing adequate gas exchange, a pH of 6.0±0.5, and calcium carbonate to facilitate the digestive processes of the worm on organic matter.
Patent MX-2021010219-A (MX)
Title: Composition for use in the prevention and/or treatment of dysbiosis.
Inventor: DUMINY HÉLÈNE
IPC: A61K31/202
Filed: 2020-03-05
Abstract: The present invention relates to a nutraceutical composition comprising one or more sources of fibres, glutamine, one or more probiotics, one or more sources of omega-3 and one or more antioxidants, for use in the prevention and/or treatment of dysbiosis of the intestinal microbiota. The present invention also relates to a method for the prevention and/or treatment of dysbiosis comprising a step of administration to a patient in need of the composition according to the invention. The present invention also relates to a three-part kit for use in the prevention and/or treatment of dysbiosis of the intestinal microbiota.
Patent MX-2021011220-A (MX)
Title: Pneumatic valve / pressure vessel subcomponent with bayonet retention feature.
Inventor: RILEY BRIAN J
IPC: B60T17/04
Filed: 2020-02-24
Abstract: A valve assembly including a fastener-less subcomponent (410). Installation of the subcomponent is simplified as compared to cover plates utilizing fasteners, while still providing suitable performance. In addition, the fastener-less subcomponent is not readily disassembled with common tools thereby discouraging tampering. The subcomponent includes bayonet style features for interlocking with structure of a valve housing to lock the subcomponent in position.
Patent MX-2021014564-A (MX)
Title: Medical hollow article, medical hollow article having a closure cap, method for producing a medical hollow article, and kit.
Inventor: GLOCKER JOACHIM
IPC: A61M5/28
Filed: 2020-05-26
Abstract: The invention relates to a medical hollow article (1) made of glass, the medical hollow article (1) having a fastening portion (3) and a holding portion (5), the fastening portion (3) having a shoulder region (7) and a head region (9), and the head region (9) having an opening (11), on which a closure cap (13) can be arranged. According to the invention, the fastening portion (3) has at least one rotation-inhibiting structure (15), which is designed to at least inhibit relative rotation between the medical hollow article (1) and the closure cap (13), the rotation-inhibiting structure (15) having at least one rotation-inhibiting element (17), the at least one rotation-inhibiting element (17) being at least one elevation and/or at least one recess, and/or being in the form of a non-circular shape of the opening (11) and/or a non-circular edge of the opening (11).
Patent MX-2021014638-A (MX)
Title: Non-nicotine e-vaping section, and non-nicotine e-vaping device including non-nicotine e-vaping section.
Inventor: WEIGENSBERG ISAAC
IPC: A24F40/42
Filed: 2020-07-30
Abstract: The non-nicotine e-vaping section includes a housing (12), a wick (64) in a chamber (72) defined within the housing, a heater (60) in heating proximity to the wick, and a reservoir (62) configured to contain a non-nicotine pre-vapor formulation (21), the non-nicotine pre-vapor formulation being devoid of nicotine and including at least one non- nicotine compound. The non-nicotine e-vaping section defines at least one first channel (66), the at least one first channel being configured to communicate the non-nicotine pre-vapor formulation from the reservoir to the wick. The non-nicotine e-vaping section further defines at least one first air passage (68), the at least one first air passage being configured to allow air to enter the reservoir. The non- nicotine e-vaping device includes the non-nicotine e-vaping section.
Patent MX-2021015576-A (MX)
Title: Extended release gastroretentive formulation against helicobacter pylori.
Inventor: LE TIEN CANH
IPC: A61K31/357
Filed: 2020-06-26
Abstract: The present document describes extended release gastro retentive dosage form comprising a carboxylated polysaccharide and cinnamaldehyde conjugate formed via an acetal, hemiacetal or cyclic hemiacetal formed between an aldehyde group of the cinnamaldehyde and a hydroxyl group of the carboxylated polysaccharide. The document also describes extended release gastro retentive dosage form comprising an artesunate emulsion having a pH value of from about 7.5 to 7.9 and comprising an artesunate or pharmaceutically acceptable salts thereof, and stereoisomers thereof stabilized with an emulsifying agent. The document also describes the use of the dosage forms for treatment of H. Pylori infection.
Patent MX-2021015779-A (MX)
Title: Strainer.
Inventor: OCHIAI MASARU
IPC: B01D29/11
Filed: 2021-12-15
Abstract: Provided is a compact strainer having a small pressure loss which can be easily cleaned without inserting and detaching screens in and from the casing of the strainer. [Solution Means] The front and rear end portions 2, 3 of a tubular casing 1 are respectively provided with an inlet 4 and an outlet 5 each having a diameter smaller than the inner diameter of the casing 1, a barrier 6 that divides in two the linear channel between the inlet 4 and the outlet 5 along the flowing direction is provided on the outlet 5 side vertically throughout in the casing 1 so as to face the inlet 4, a filter portion 8 surrounding the inlet 4 is constituted by the barrier 6, a pair of screens 7 laterally opposing each other arranged at a predetermined interval, and the upper and lower portions of an inner surface lb of an outer wall la of the casing 1, and upper and lower regions of the outer wall la are provided with opening portions 10 with lids 9 which make the inside of the filter portion 8 communicate with the outside.
Patent MX-2022000923-A (MX)
Title: Portable holding chamber.
Inventor: MEYER ADAM
IPC: A61M15/00
Filed: 2020-07-17
Abstract: A medication delivery system having a holding chamber capable of delivering dosages of medicament from a metered dose inhaler. The holding chamber includes a first housing component having a user interface with an outlet opening and a second housing component having an inlet opening spaced apart from the outlet opening of the first housing component. The first housing component is pivotally connected to the second housing component about a pivot axis.
Patent MX-2022001010-A (MX)
Title: Enhanced rodeferin broad spectrum.
Inventor: REYNOLDS ROBERT
IPC: A61K31/5415
Filed: 2022-01-24
Abstract: This process manufactures a finished medicine that can be used against broad spectrum, Anti-Viral, Anti-Bacterial, Anti-Fungal, and Anti-parasitic disease conditions that attack the human body but not limited to other medical conditions and or other types of treatments use for animals other than humans.
Patent MX-2022002723-A (MX)
Title: Dimeric antigen receptors (dar) that bind bcma.
Inventor: KAUFMANN GUNNAR F
IPC: A61K35/17
Filed: 2020-09-04
Abstract: The present disclosure provides dimeric antigen receptors (DAR) constructs that bind a BCMA target antigen, where the DAR construct comprises a heavy chain binding region on one polypeptide chain and a light chain binding region on a separate polypeptide chain. The two polypeptide chains that make up the dimeric antigen receptors can dimerize to form an antigen binding domain. The dimeric antigen receptors have antibody-like properties as they bind specifically to a target antigen. The dimeric antigen receptors can be used for directed cell therapy.
Patent MX-2022003916-A (MX)
Title: Use of simultaneous marker detection for assessing difuse glioma and responsiveness to treatment.
Inventor: RODRIGUEZ ANALIZ
IPC: C12Q1/6869
Filed: 2020-10-12
Abstract: The present disclosure relates to a method to detect simultaneously mutations and methylation levels in a biological sample of a subject. In particular the present disclosure is directed to a method for diagnosing a central nervous system tumor such as a diffuse glioma, in a subject and comprises the steps of - determining at the same time the presence or absence of a mutation and methylation levels in one or more regions of interest.
Patent MX-2022005650-A (MX)
Title: Therapeutic agent and prophylactic agent for functional gastrointestinal disorders and xerostomia.
Inventor: YOSHINAGA Ryohei
IPC: A61K31/496
Filed: 2020-11-12
Abstract: Provided is a novel prophylactic agent or therapeutic agent for functional gastrointestinal disorders or xerostomia. The present invention is a therapeutic agent or prophylactic agent that is for functional gastrointestinal disorders and that contains, as an active ingredient, an azabenzoimidazole compound represented by formula [1] (in the formula, the symbols are as defined in the description) or a pharmaceutically acceptable salt thereof, or a solvate thereof.
Patent MX-2022006094-A (MX)
Title: Improved intravaginal culture incubation container and method.
Inventor: WALSH JOHN E
IPC: A61D19/02
Filed: 2021-01-18
Abstract: Intravaginal culture (IVC) container for intravaginal fertilization and culture of mammalian, and in particular human, oocytes, featuring an increased volume, and a method of using the same.